SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-20-004102
Filing Date
2020-06-01
Accepted
2020-06-01 16:15:32
Documents
12
Period of Report
2020-05-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_060120.htm   iXBRL 8-K 23848
  Complete submission text file 0001171843-20-004102.txt   199888

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE gbt-20200528.xsd EX-101.SCH 3168
3 XBRL LABEL FILE gbt-20200528_lab.xml EX-101.LAB 35273
4 XBRL PRESENTATION FILE gbt-20200528_pre.xml EX-101.PRE 23135
13 EXTRACTED XBRL INSTANCE DOCUMENT f8k_060120_htm.xml XML 3675
Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37539 | Film No.: 20933584
SIC: 2834 Pharmaceutical Preparations